CN105330615B - 一种沃替西汀的制备方法 - Google Patents
一种沃替西汀的制备方法 Download PDFInfo
- Publication number
- CN105330615B CN105330615B CN201510901802.4A CN201510901802A CN105330615B CN 105330615 B CN105330615 B CN 105330615B CN 201510901802 A CN201510901802 A CN 201510901802A CN 105330615 B CN105330615 B CN 105330615B
- Authority
- CN
- China
- Prior art keywords
- completion
- vortioxetine
- preparation
- dropping
- piperazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510901802.4A CN105330615B (zh) | 2015-12-08 | 2015-12-08 | 一种沃替西汀的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510901802.4A CN105330615B (zh) | 2015-12-08 | 2015-12-08 | 一种沃替西汀的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105330615A CN105330615A (zh) | 2016-02-17 |
CN105330615B true CN105330615B (zh) | 2017-08-11 |
Family
ID=55281408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510901802.4A Active CN105330615B (zh) | 2015-12-08 | 2015-12-08 | 一种沃替西汀的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105330615B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104356092A (zh) * | 2014-11-27 | 2015-02-18 | 合肥创新医药技术有限公司 | 沃替西汀的制备方法 |
CN104529734A (zh) * | 2014-11-29 | 2015-04-22 | 湖北金赛药业有限公司 | 一种盐酸芬戈莫德的制备方法及其制备中间体 |
-
2015
- 2015-12-08 CN CN201510901802.4A patent/CN105330615B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104356092A (zh) * | 2014-11-27 | 2015-02-18 | 合肥创新医药技术有限公司 | 沃替西汀的制备方法 |
CN104529734A (zh) * | 2014-11-29 | 2015-04-22 | 湖北金赛药业有限公司 | 一种盐酸芬戈莫德的制备方法及其制备中间体 |
Also Published As
Publication number | Publication date |
---|---|
CN105330615A (zh) | 2016-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021202576B2 (en) | Fenfluramine compositions and methods of preparing the same | |
NO328542B1 (no) | Fremgangsmate og forbindelse for fremstillingen av Citalopram | |
CN114394983A (zh) | 多环氨基甲酰基吡啶酮化合物的合成 | |
CN103562195A (zh) | 通过n-丁基化制备决奈达隆的方法 | |
CN103562196A (zh) | 使用胺中间体化合物制备决奈达隆的还原胺化方法 | |
CN105503834B (zh) | 一种伏立康唑中间体的合成方法 | |
ES2644568T3 (es) | Procedimiento para la preparación de N,N-dialquilbencilaminas halogenadas en núcleo | |
CN105175329B (zh) | 一种贝达喹啉消旋体的合成路线及方法 | |
CN111303020A (zh) | 一种5-氯-2-(吡啶-3-基)吡啶-3-胺的合成方法 | |
CN102617434A (zh) | 一锅法制备维达列汀 | |
CN104788361A (zh) | 5-氮杂螺[2.4]庚烷-6-甲酸衍生物的合成方法 | |
CN105330615B (zh) | 一种沃替西汀的制备方法 | |
CN112624983A (zh) | 一种含烷基结构的联苯二芳基嘧啶类衍生物及其制备方法和应用 | |
JP4418717B2 (ja) | (z)−1−フェニル−1−ジエチルアミノカルボニル−2−アミノメチルシクロプロパン塩酸塩の製造方法 | |
IL269255A (en) | Process for the preparation of glycopyrulate tosilate | |
KR101845624B1 (ko) | 고순도 고수율의 디클로로글리옥심의 제조방법 | |
EP3896057B1 (en) | Method for continuously preparing citalopram diol | |
JP6999112B2 (ja) | 2,5-ビス(アミノメチル)フラン二ハロゲン化水素塩及びその製造方法並びに2,5-ビス(アミノメチル)フランの製造方法 | |
CN106831652B (zh) | 一种沃赛汀的制备方法 | |
CN105859648B (zh) | 一种制备帕拉米韦中间体的方法 | |
CN112375004B (zh) | 一种2-(2-氨基乙氧基)-1,1-二甲氧基乙烷的制备方法 | |
CN102757320B (zh) | 一种阿利克伦中间体的制备方法 | |
CN107698509B (zh) | 一种脱氢伊伐布雷定草酸盐的制备方法 | |
CN113354652A (zh) | 一种盐酸纳美芬合成方法 | |
CN108440434A (zh) | 一种缬沙坦的新杂质以及合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200225 Address after: No. 10678, Wenliang Road, Dongjia street, Licheng District, Jinan City, Shandong Province Patentee after: Shandong Anxin Pharmaceutical Co., Ltd Address before: 250105 No. 849 Dong Jia town, Licheng District, Shandong, Ji'nan Patentee before: QILU TIANHE PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201104 Address after: 570314 -A, Nanhai Avenue, national hi tech Development Zone, Hainan, Haikou, 273 Patentee after: QILU PHARMACEUTICAL (HAINAN) Co.,Ltd. Patentee after: Shandong Anxin Pharmaceutical Co.,Ltd. Address before: No. 10678, Wenliang Road, Dongjia street, Licheng District, Jinan City, Shandong Province Patentee before: Shandong Anxin Pharmaceutical Co.,Ltd. |